Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Rx Item-Glycopyrrolate USP 1gm By Letco Medical

Glycopyrrolate, USP 1gm By Letco Medical Item No.Letco610950 NDC No. 62991-2886-01 62991288601 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers,Just change the quantity and save!Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.COMPOUNDING ITEMS SPECIALIST

Rx Item-Glycopyrrolate USP 1gm By Letco Medical

$1009.65$504.76

Item No.:RX-LETCO610950, Glycopyrrolate, USP 1gm By Letco Medical Item No.Letco610950 NDC No. 62991-2886-01 62991288601 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers, Hospitals, Government, Va, Physician Assistants, Nurse Practitioners , Podiatrists, Opticians, Optometrists, Veterinarians, Naturalists, Licensed Labs, Physical Therapists & Pharmacists In Their Scope Of Practice. UPC No.: 96546475182900

Have a question?

GLYCOPYRROLATE, USP 1GM by Letco Medical Safety Data Sheet Section 1: Identification Common Name/Trade Name GLYCOPYRROLATE USP Supplier Information Letco Medical, LLC 1316 Commerce Drive NW Decatur, AL 35601 1 (800) 239-5288 +1 (734) 843-4693 IN CASE OF EMERGENCY: Chemtrec 1 (800) 424-9300 (24 hours) Product Synonym(s) GCP. 1-dimethyl-, bromide", "3-[(cyclopentylhydroxyphenylacetyl)oxy]-1 Relevant Use(s) of Product Manuf acture or Compounding of Substances Section 2: Hazards Identification Classification of Substance or Mixture Skin irritation (Category 2), Eye irritation (Category 2), Specif ic target organ toxicity - single exposure (Category 3) Signal Word Warning Hazard Statement(s) H315 Causes skin irritation H319 Causes serious eye irritation H335 May cause respiratory irritation Pictogram(s) Precautionary Statement(s) P261 Avoid breathing dust/f ume/gas/mist/vapours/spray. P305+P351+P338 IF IN EYES Rinse cautiously with water f or several minutes. Remove contact lenses if present and easy to do. continue rinsing. Hazards Not Otherwise Classified Other hazards - None Ingredient(s) with Unknown Toxicity No data available Section 3: Composition/Information on Ingredients Chemical Name Glycopyrrolate Common Name Glycopyrrolate CAS Number 596-51-0 Impurities and/or Stabilizing Additives No data available Section 4: First Aid Measures General Advice Consult a physician. Show this saf ety data sheet to the doctor in attendance. If Inhaled If breathed in, move person into fresh air. If not breathing, give artif icial respiration. Consult a physician. In Case of Skin Contact Wash of f with soap and plenty of water. Consult a physician. In Case of Eye Contact Rinse thoroughly with plenty of water f or at least 15 minutes and consult a physician. If Swallowed Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician. Most Important Symptoms and Effects Acute Health Ef f ects: Swallowed: Accidental ingestion of the material may be harmf ul; animal experiments indicate that ingestion of less than 150 gram may be f atal or may produce serious damage to the health of the individual. Anti cholinergics can cause loss of vision. Ef f ects associated with their use include increased heart rate, decreased saliva production and other secretions and reduction in bowel movements. Adverse ef f ects include dry mouth, dif f iculty swallowing and speaking, thirst, dilated pupils, loss of f ocus, sensitivity to light, skin f lushing and dryness, a temporary slowing of heart rate f ollowed by rapid heart rate with palpitations and irregularities in rhythm. There may be vomiting, pain in the chest and dizziness. Toxicity due to overdose may result in rapid breathing, high f ever, restlessness, conf usion, excitement, paranoia, psychosis, hallucinations, delirium, seizures and convulsions. A rash may occur on the f ace or upper trunk. Severe intoxication can depress the central nervous system, causing inco-ordination, drowsiness, stupor, unconsciousness, coma, stoppage of circulation and breathing, and death. Quaternary ammonium ant cholinergic agents, in high doses, can cause postural hypotension and impotence. Paralysis may occur at very high doses Page 1 of 5 Section 5: Fire Fighting Measures Suitable Extinguishing Media Use water spray, alcohol-resistant f oam, dry chemical or carbon dioxide. Special Hazards Arising From the Substance/Mixture No data available Special PPE and/or Precautions for Firefighters Wear self contained breathing apparatus f or f ire f ighting if necessary. Section 6: Accidental Release Measures Personal Precautions, Protective Equipment and Emergency Procedures Use personal protective equipment. Avoid dust f ormation. Avoid breathing vapours, mist or gas. Ensure adequate ventilation. Evacuate personnel to saf e areas. Avoid breathing dust. Methods and Materials Used for Containment Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers f or disposal. Cleanup Procedures Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed containers f or disposal. Do not let product enter drains. Section 7: Handling and Storage Precautions for Safe Handling Avoid contact with skin and eyes. Avoid f ormation of dust and aerosols. Provide appropriate exhaust ventilation at places where dust is f ormed. Avoid breathing dust If in eyes : Rinse cautiously with water f or several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Conditions for Safe Storage Store in original containers. Keep containers securely sealed. Store in a cool, dry, well-ventilated area. Store away from incompatible materials and f oodstuf f containers. Protect containers against physical damage and check regularly f or leaks. Observe manuf acturer's storing and handling recommendations. NOTE: Store in the dark. Section 8: Exposure Controls/Personal Protection Components with Workplace Control Parameters No data available Appropriate Engineering Controls Handle in accordance with good industrial hygiene and saf ety practice. Wash hands bef ore breaks and at the end of workday. Do not let product enter drains. PPE - Eye/Face Protection Use Saf ety glasses with side �?¢?? shields. Use equipment f or eye protection. PPE - Skin Protection Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique to avoid skin contact with this product. Dispose of contaminated gloves af ter use in accordance with applicable laws and good laboratory practices. Wash and dry hands PPE - Body Protection Impervious clothing. The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specif ic workplace. PPE - Respiratory Protection For nuisance exposures use particle respirator. For higher level protection use respirator cartridges. Use respirators and components tested and approved under appropriate government standards Page 2 of 5 Section 9: Physical and Chemical Properties Appearance Form: Solid Upper/Lower Flammability or Explosive Limits No data available Odor No data available Vapor Pressure No data available Odor Threshold No data available Vapor Density No data available pH Neutral Relative Density No data available Melting Point/Freezing Point 193-198 °C Solubility mixes with water (1:4.2), alcohol (1:30) Initial Boiling Point and Boiling Range No data available Flash Point Not applicable Evaporation Rate No data available Flammability (Solid, Gas) No data available Partition Coefficient No data available Auto-Ignition Temperature No data available Decomposition Temperature No data available Viscosity No data available Section 10: Stability and Reactivity Reactivity No data available Chemical Stability Stable under normal temperature and pressures or recommended conditions. In dry f orm relatively stable to light. Possibility of Hazardous Reactions No data available Conditions to Avoid Presence of incompatible materials. Product is considered stable. Hazardous polymerization will not occur. Incompatible Materials Strong oxidizing agent Hazardous Decomposition Products Hazardous polymerization will not occur. Page 3 of 5 Section 11: Toxicological Information Acute Toxicity - LD50 Oral Oral (rat) LD50: 709 mg/kg Nil Reported. Intraperitoneal (rat) LD50: 90 mg/kg. Subcutaneous (mouse) LD50: 122 mg/kg. Intravenous (mouse) LD50: 15 mg/kg Oral (rabbit) LD50: 2360 mg/kg Intravenous (rabbit) LD50: 29.1 mg/kg. Oral toxicity (Mouse) LD50: 570 mg/kg Oral LD50 in mice 107 mg / kg i.p.; >1 g / kg Acute Toxicity - Inhalation The material is not thought to produce adverse health ef f ects or irritation of the respiratory tract (as classif ied by EC Directives using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting. Persons with impaired respiratory f unction, airway diseases and conditions such as emphysema or chronic bronchitis, may incur f urther disability if excessive concentrations of particulate are inhaled. If prior damage to the circulatory or nervous systems has occurred or if kidney damage has been sustained, proper screenings should be conducted on individuals who may be exposed to f urther risk if handling and use of the material result in excessive exposures. Acute Toxicity - Dermal No data available Acute Toxicity - Eye Although the material is not thought to be an irritant (as classif ied by EC Directives), direct contact with the eye may produce transient discomf ort characterised by tearing or conjunctival redness (as with windburn). The dust may produce eye discomf ort causing smarting, pain and redness. Ant cholinergic eye drops can cause stinging, dryness, redness, itch, dilated pupils, and loss of f ocus with blurred vision. Pupil Ref lexes may be lost or diminished f or 3 days. Skin Corrosion/Irritation The material is not thought to produce adverse health ef f ects or skin irritation f ollowing contact (as classif ied by EC Directives using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting. Toxic ef f ects may result from skin absorption. Serious Eye Damage/Irritation No data available Respiratory or Skin Sensitazation No data available Germ Cell Mutagenicity No data available Carcinogenicity IARC No data available Carcinogenicity ACGIH No data available Carcinogenicity NTP No data available Carcinogenicity OSHA No data available Reproductive Toxicity No data available Specific Target Organ Toxicity - Single Exposure No data available Specific Target Organ Toxicity - Repeated Exposure Principal routes of exposure are by accidental skin and eye contact and inhalation of generated dusts. Prolonged exposure to anti cholinergic agents may irritate the eyes, causing allergic lid reactions, conjunctivitis, swelling, excess blood f low to the eyes, and sensitivity to light. Increase in eye pressure may lead to closed angle glaucoma. There may be hypersensitivity shown by conjunctivitis, rash and eczema. Anti cholinergics can also cause chronic constipation with blockage of the intestine by f aeces. Aspiration Hazard No data available Section 12: Ecological Information Toxicity No data available Persistence and Degradability No data available Bio-accumulative Potential Air. The products of degradation are as toxic as the product itself . Possibly hazardous short term degradation products are not likely. However, long term degradation products may arise. Mobility in Soil Water/Soil. Other Adverse Effects No data available Section 13: Disposal Considerations Waste Treatment Methods Product Recycle wherever possible. Special hazard may exist - specialist advice may be required. Consult manuf acturer f or recycling options. Consult State Land Waste Management Authority f or disposal. Bury or incinerate residue at an approved site. Decontaminate empty containers. Observe all label saf eguards until containers are cleaned and destroyed. Puncture containers to prevent re-use and bury at an authorised landf ill. Observe local/national regulations regarding waste disposal. Waste Treatment Methods Packaging Recycle wherever possible. Special hazard may exist - specialist advice may be required. Consult manuf acturer f or recycling options. Consult State Land Waste Management Authority f or disposal. Bury or incinerate residue at an approved site. Decontaminate empty containers. Observe all label saf eguards until containers are cleaned and destroyed. Puncture containers to prevent re-use and bury at an authorised landf ill. Observe local/national regulations regarding waste disposal. Special Precautions Landfill or Incinerations No data available Other Information No data available Page 4 of 5 Section 14: Transport Information UN Number Not dangerous goods. UN Proper Shipping Name N/A Transport Hazard Class(es) N/A Packaging Group N/A Environmental Hazards N/A Section 15: Regulatory Information No f urther data available. Section 16: Other Information Additional Information N/A Prepared By Lisa Russell Revision Date 01/11/2019 14:27 Disclaimer Letco Medical, LLC believes that the above information is correct but does not purport to be all inclusive and shall be used only as a guide. The information in this document is based on the present state of our knowledge and is applicable to the product with regard to appropriate safety precautions. If the product is used as a component in another product, this information may not be applicable. NO WARRANTY OF FITNESS FOR ANY PARTICULAR PURPOSE, WARRANTY OF MERCHANTABILITY OR ANY OTHER WARRANTY, EXPRESSED OR IMPLIED, IS MADE CONCERNING THE INFORMATION PROVIDED ABOVE. Letco Medical shall not be held liable for any loss or damage resulting from handling, storage, use or from contact with the above product. Page 5 of 5

Glycopyrrolate, USP 1gm By Letco Medical Item No.Letco610950 NDC No. 62991-2886-01 62991288601 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers,
GLYCOPYRROLATE, USP 1GM by Letco Medical
Glycopyrrolate, USP 1gm By Letco Medical Item No.Letco610950 NDC No. 62991-2886-01 62991288601 Category: Rx This Prescription Item Can Only Be Ordered By Physicians, Pharmacies, Dentists, Wholesalers,

Just change the quantity and save!
Buy more Save More!
Just change the quantity and save!

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

COMPOUNDING ITEMS SPECIALIST
LETCO MEDICAL
COMPOUNDING ITEMS SPECIALIST